Pentixapharm Holding AG (ETR:PTP) | WebDisclosure

Basculer en Français

9815	Companies
196878	Keywords
127940	Articles
104700	Press releases

Headlines Articles Press releases Pentixapharm Holding AG

Home
Companies
Pentixapharm Holding AG

PRESS RELEASE

published on 01/24/2025 at 17:00, 1 year ago

EQS-Adhoc: Pentixapharm Holding AG Closes the 2024 Financial Year With a Loss of EUR 14 Million, Including Risk Provisions for Myelo Amounting to EUR 7 Million
Pentixapharm Holding AG reports a 2024 financial year loss of EUR 14 million, including risk provisions for Myelo. Find more details in the upcoming annual report

Annual Report Risk Provisions Pentixapharm Holding AG Financial Year Loss Myelo
BRIEF

published on 01/07/2025 at 10:35, 1 year ago

Pentixapharm obtient 6,77 millions d'euros auprès des actifs de Glycotope

Transaction Pentixapharm Glycotope Acquisition Pharmaceutique Actifs Incorporels
BRIEF

published on 01/07/2025 at 10:35, 1 year ago

Pentixapharm Secures EUR 6.77 Million from Glycotope Assets

Transaction Pentixapharm Glycotope Pharmaceutical Acquisition Intangible Assets
PRESS RELEASE

published on 01/07/2025 at 10:30, 1 year ago

Pentixapharm Receives EUR 6.77 Million for Intangible Assets Formerly Developed by Glycotope
Pentixapharm receives EUR 6.77 million for intangible assets formerly developed by Glycotope from undisclosed Asian pharma and biotech companies, eliminating remaining earn-out obligations

Acquisition Pharma Pentixapharm Glycotope Intangible Assets
PRESS RELEASE

published on 11/21/2024 at 13:41, 1 year 2 months ago

Original-Research: Pentixapharm Holding AG (von BankM AG): Kaufen
Pentixapharm Holding AG gibt den Start der klinischen Studie PENTILULA bekannt, um AML und ALL zu behandeln. Analysten bestätigen Kaufempfehlung und Kursziel. Neue Therapie mit Lutetium-177

Pentixapharm Holding AG Lutetium-177 PENTILULA AML ALL
BRIEF

published on 11/21/2024 at 11:05, 1 year 2 months ago

Pentixapharm Advancing Clinical Trials for Leukemia Treatment

Clinical Trial Radiopharmaceuticals Pentixapharm Lu-177 Leukemia Treatment
BRIEF

published on 11/21/2024 at 11:05, 1 year 2 months ago

Pentixapharm fait progresser les essais cliniques pour le traitement de la leucémie

Essai Clinique Produits Radiopharmaceutiques Pentixapharm Lu-177 Traitement De La Leucémie
PRESS RELEASE

published on 11/21/2024 at 11:00, 1 year 2 months ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Pentixapharm starts Phase I/II trial treating leukemia with Lu177-PentixaTher, a targeted radiotherapy. Study aims to expand treatment options for hematologic malignancies

Phase I/II Trial Leukemia Pentixapharm Radiotherapy Lu177-PentixaTher
BRIEF

published on 11/12/2024 at 17:50, 1 year 2 months ago

Pentixapharm publie ses résultats intermédiaires du troisième trimestre 2024

Perte Financière Spin Off Rapport Intérimaire Pentixapharm Troisième Trimestre
BRIEF

published on 11/12/2024 at 17:50, 1 year 2 months ago

Pentixapharm Reports Third Quarter 2024 Interim Results

Interim Report Spin-off Financial Loss Third Quarter Pentixapharm

Accesswire

Published on 02/05/2026 at 18:50, 28 minutes ago

Athena Gold Provides Exploration Update From Nevada and Ontario
Published on 02/05/2026 at 17:35, 1 hour 43 minutes ago

Pentagon I Capital Corp. Enters into Letter Agreement to Complete Qualifying Transaction with Prospectiva Resources Ltd.
Published on 02/05/2026 at 16:40, 2 hours 38 minutes ago

Relevant Gold Appoints Larry Taddei to Board of Directors and Mal Karwowska as Strategic Advisor
Published on 02/05/2026 at 15:45, 3 hours 33 minutes ago

American Critical Minerals Recaps a Highly Successful 6 Months and Files Amended and Restated Technical Report
Published on 02/05/2026 at 15:10, 4 hours 8 minutes ago

Electric Metals (USA) Limited Announces Change of Auditor

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 18:46, 32 minutes ago

EQS-Adhoc: Mayr-Melnhof Karton AG: Impairment requirements impact profit for the financial year 2025
Published on 02/05/2026 at 18:09, 1 hour 8 minutes ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/05/2026 at 17:55, 1 hour 23 minutes ago

Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
Published on 02/05/2026 at 17:40, 1 hour 38 minutes ago

BROADPEAK SA: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social au 01.02.26.
Published on 02/05/2026 at 17:40, 1 hour 38 minutes ago

UV GERMI : MISE À DISPOSITION DE LA NOTE D’INFORMATION ET DU DOCUMENT « AUTRES INFORMATIONS » DANS LE CADRE DE L’OFFRE PUBLIQUE DE RACHAT D’ACTIONS INITIÉE PAR UV GERMI

Les Echos

Published on 02/05/2026 at 19:15, 3 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 3 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026
Published on 02/05/2026 at 18:43, 35 minutes ago

COMMUNIQUÉ RELATIF AU DÉPOT D’UN PROJET D’OFFRE PUBLIQUE DE RETRAIT SUIVIE D’UN RETRAIT OBLIGATOIRE VISANT LES ACTIONS ET LES BSAR B DE LA SOCIÉTÉ
Published on 02/05/2026 at 18:24, 54 minutes ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:12, 1 hour 6 minutes ago

LNA SANTE : Chiffre d'affaires annuel 2025

View all LES ECHOS COMFI WIRE